What is Cepham?
Cepham is a seasoned player in the natural health industry, specializing in the development and manufacturing of evidence-based nutraceutical ingredients and innovative delivery systems. With nearly five decades of experience, the company leverages its deep expertise in medical science to drive research and development, focusing on ingredient efficacy and quality. This commitment ensures that clients receive high-impact, reliable raw materials to create remarkable new products.
How much funding has Cepham raised?
Cepham has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Cepham
PPP
Public-Private Partnership
What's next for Cepham?
The recent strategic investment signals a pivotal moment for Cepham, likely enabling the company to accelerate its product development pipeline, expand its manufacturing capabilities, and potentially broaden its market reach. This capital will be instrumental in furthering its research into novel delivery systems and reinforcing its position as a provider of high-quality, science-backed nutraceutical ingredients. The company is poised to capitalize on emerging trends in the health and wellness sector, driving innovation and delivering value to its partners.
See full Cepham company page
